Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnosis and treatment of KIT-mutant metastatic melanoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Sept 2013

Lyle Megan, Long Georgina V

Abstract excerpt

A 52-year-old man has unresectable locally recurrent melanoma of the left foot (Fig 1) and pulmonary metastases. Nine months before this presentation, he underwent a wide local excision and sentinel node biopsy for an acral melanoma on his left heel. Pathology disclosed Breslow thickness of 4.8 m...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neoplasm Recurrence, Local
Share to Biomarkers, Tumor
Share to gp100 Melanoma Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Melanoma

Share to Proto-Oncogene Proteins c-kit

Share to S100 Proteins

Share to Skin Neoplasms

Source

Identifiers

PMID: 23940219
DOI: 10.1200/JCO.2013.50.4662

Genes

KIT
BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23940219-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnosis and treatment of KIT-mutant metastatic melanoma.PMID 23940219Read ↗

Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeutics.Semantic proximity Read ↗

Principles of Targeted Therapy for Melanoma.Semantic proximity Read ↗

Targeting mutant BRAF and KIT in metastatic melanoma: ASCO 2009 meeting report.Semantic proximity Read ↗

KIT as a therapeutic target in metastatic melanoma.Semantic proximity Read ↗

Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT.Semantic proximity Read ↗

Targeting activated KIT signaling for melanoma therapy.Semantic proximity Read ↗

Pharmacological inhibitors of c-KIT block mutant c-KIT mediated migration of melanocytes and melanoma cells in vitro and in vivo.Semantic proximity Read ↗

Imatinib targeting of KIT-mutant oncoprotein in melanoma.Semantic proximity Read ↗

Novel somatic KIT exon 8 mutation with dramatic response to imatinib in a patient with mucosal melanoma: a case report.Semantic proximity Read ↗

KIT gene mutations and patterns of protein expression in mucosal and acral melanoma.Semantic proximity Read ↗

C-Kit non-mutated metastatic melanoma showing positive response to Nilotinib.Semantic proximity Read ↗

Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.